Delivery Order SPE2DB20D1109-SPE2DB25FP71S
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies on August 14, 2025, with a ceiling value of $1,143.87. This non-set-aside, competitively awarded contract calls for the delivery of Zepbound 15 mg/0.5 mL pen injections, a GLP-1 receptor agonist medication used in weight management and diabetes treatment. The order is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price, competitively awarded delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $25,048.41 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen (0.5 ml), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-competitive award under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens, a GLP-1 receptor agonist medication used for weight management. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,050.40 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $9,506.79 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement for a pharmaceutical product commonly used in diabetes and weight management treatment. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance of work...
- The Defense Logistics Agency has awarded a delivery order valued at $2,425.15 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens, a glucagon-like peptide-1 (GLP-1) receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by July 24, 2025. The award was issued on July 23, 2025, with performance to be executed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,090.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 7, 2025. This firm fixed-price delivery order is non-competitive and represents a single shipment of the diabetes and weight management medication to support federal healthcare requirements. The contract will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025....
- The Defense Logistics Agency awarded a $28,634.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on August 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which runs through December 2026. The performance location is the company's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a $7,509.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on August 19, 2025, with ultimate completion scheduled for August 20, 2025. This competitive award, placed under no set-aside designation, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement...
- The Defense Logistics Agency awarded a $2,089.68 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens, a GLP-1 receptor agonist indicated for weight management. This firm fixed-price delivery order, which will be completed by August 12, 2025, represents a direct purchase under an existing contract vehicle and carries no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This...